ATE515699T1 - Verwendung von adiponectin als marker in der vorhersage post-operativer infektion - Google Patents

Verwendung von adiponectin als marker in der vorhersage post-operativer infektion

Info

Publication number
ATE515699T1
ATE515699T1 AT05727482T AT05727482T ATE515699T1 AT E515699 T1 ATE515699 T1 AT E515699T1 AT 05727482 T AT05727482 T AT 05727482T AT 05727482 T AT05727482 T AT 05727482T AT E515699 T1 ATE515699 T1 AT E515699T1
Authority
AT
Austria
Prior art keywords
adiponectin
marker
prediction
post
operative infection
Prior art date
Application number
AT05727482T
Other languages
English (en)
Inventor
Kazuhisa Maeda
Hiroshi Yamamoto
Original Assignee
Kazuhisa Maeda
Hiroshi Yamamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kazuhisa Maeda, Hiroshi Yamamoto filed Critical Kazuhisa Maeda
Application granted granted Critical
Publication of ATE515699T1 publication Critical patent/ATE515699T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
AT05727482T 2004-03-31 2005-03-31 Verwendung von adiponectin als marker in der vorhersage post-operativer infektion ATE515699T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004134823 2004-03-31
JP2004134824 2004-03-31
PCT/JP2005/006395 WO2005094188A2 (ja) 2004-03-31 2005-03-31 侵襲管理方法及びアディポネクチンの利用

Publications (1)

Publication Number Publication Date
ATE515699T1 true ATE515699T1 (de) 2011-07-15

Family

ID=35064193

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05727482T ATE515699T1 (de) 2004-03-31 2005-03-31 Verwendung von adiponectin als marker in der vorhersage post-operativer infektion
AT10185392T ATE544467T1 (de) 2004-03-31 2005-03-31 Adiponectin als endotoxin neutralisierendes agenz

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT10185392T ATE544467T1 (de) 2004-03-31 2005-03-31 Adiponectin als endotoxin neutralisierendes agenz

Country Status (8)

Country Link
US (2) US20080139468A1 (de)
EP (2) EP2279745B1 (de)
JP (2) JP4771940B2 (de)
KR (2) KR101223355B1 (de)
CN (1) CN1969187A (de)
AT (2) ATE515699T1 (de)
ES (1) ES2365923T3 (de)
WO (1) WO2005094188A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE515699T1 (de) 2004-03-31 2011-07-15 Kazuhisa Maeda Verwendung von adiponectin als marker in der vorhersage post-operativer infektion
JP5432567B2 (ja) 2008-04-16 2014-03-05 花王株式会社 アディポネクチン分泌調節剤の評価又は選択方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6135473A (ja) * 1984-07-27 1986-02-19 Konishiroku Photo Ind Co Ltd 複写機における記録紙案内装置
DE4237502A1 (de) * 1992-11-06 1994-05-11 Biometec Ges Fuer Bio Medizini Arzneimittel enthaltend Antiidiotyp-Antikörper gegen Anti-CD14-Antikörper
JP3018186B1 (ja) 1999-03-09 2000-03-13 大阪大学長 抗炎症剤、単球系細胞の増殖抑制剤
BR0107626A (pt) * 2000-01-14 2002-10-15 Genset Sa Cabeças globulares de obg3 e usos destes para diminuir a massa corporal
DK1426764T3 (da) * 2001-08-17 2011-06-27 Fujirebio Kk Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme
EP1458758A2 (de) * 2001-12-21 2004-09-22 Maxygen Aps Adiponectin-fragmente und -konjugate
JP2005535561A (ja) * 2002-01-18 2005-11-24 プロテミックス コーポレイション リミティド アディポネクチンのグリコアイソフォームとその使用
WO2004022596A1 (en) * 2002-09-05 2004-03-18 Komed Co., Ltd. Monoclonal antibody against adiponectin, preparation method and use thereof
ATE515699T1 (de) 2004-03-31 2011-07-15 Kazuhisa Maeda Verwendung von adiponectin als marker in der vorhersage post-operativer infektion

Also Published As

Publication number Publication date
KR20110128941A (ko) 2011-11-30
KR101223355B1 (ko) 2013-01-16
JP4771940B2 (ja) 2011-09-14
WO2005094188A3 (ja) 2005-12-08
JPWO2005094188A1 (ja) 2008-02-14
JP2011121959A (ja) 2011-06-23
EP2279745A3 (de) 2011-02-16
ES2365923T3 (es) 2011-10-13
US9341634B2 (en) 2016-05-17
EP1744160A4 (de) 2008-05-21
EP1744160A2 (de) 2007-01-17
CN1969187A (zh) 2007-05-23
EP1744160B1 (de) 2011-07-06
US20080139468A1 (en) 2008-06-12
US20130302833A1 (en) 2013-11-14
ATE544467T1 (de) 2012-02-15
EP2279745A2 (de) 2011-02-02
EP2279745B1 (de) 2012-02-08
WO2005094188A2 (ja) 2005-10-13
KR20070026485A (ko) 2007-03-08

Similar Documents

Publication Publication Date Title
DE602005022859D1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
DE602005009318D1 (de) Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren
DE60134425D1 (de) Verwendung von mittels Milchsäurebakterien fermentiertem Reis in der Kosmetik oder als Emulgator
FI20031699L (fi) Järjestely, menetelmä ja tietokoneohjelma ihmisen fyysisen aktiivisuustason määrittämiseksi
ATE415662T1 (de) Bestimmung der tatsächlichen zeit, die ein prozessor bei der ausführung eines codeteiles aufwendet
ATE529042T1 (de) Verfahren zur quantifizierung des herztodrisikos unter verwendung von übungsinduzierten herzfrequenzvariabilitätsmetriken
TW200722753A (en) Meter having multi-level user interface
DE502005006470D1 (de) Verwendung von sulfonylharnstoffen
ATE526971T1 (de) Pimobendan zur verwendung zur verringerung der herzgrösse von säugetieren mit herzinsuffizienz
ATE443703T1 (de) Prolinderivate als ns3-serine protease hemmer, zur verwendung bei der bekämpfung von hepatitis c virusinfektion
EP1758597A4 (de) Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
DE602005013923D1 (de) Derivate von piperidinylalkylcarbamaten, herstellungsverfahren davon und verwendung derselben als faah-enzym-inhibitoren
ATE445402T1 (de) Neue verwendung von pde5-hemmern
ATE486878T1 (de) Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
DE602006018721D1 (de) Cyanidfreie lösungsmittelzusammensetzung und verwendungsverfahren dafür zur messung von hämoglobin und weissen blutkörperchen
DE602005008325D1 (de) Quantifizierung von Enzymaktivität mittels planarer Wellenleiter
ATE476986T1 (de) Verfahren zur steigerung der lymphatischen funktion
DE602005007817D1 (de) Analyse-Verfahren unter Verwendung von abgeschwächter Totalreflektion
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
ATE544467T1 (de) Adiponectin als endotoxin neutralisierendes agenz
DE602004001509D1 (de) Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung
ATE471693T1 (de) Nachweis von ischämie
SE0900647L (sv) Prognostiskt förfarande
CY1112512T1 (el) ΜΕΤΑΛΛΑΓΜΕΝΕΣ ΠΡΩΤΕΪΝΕΣ ΘΕΣΗΣ ΓΛΥΚΟΖΥΛΙΩΣΗΣ ΤIr3 ΚΑΙ ΜΕΘΟΔΟΙ ΧΡΗΣΗΣ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties